TAPI NL BV

Overview

TAPI NL BV is an active pharmaceutical ingredient (API) supplier with 330 active FDA Type II Drug Master Files, covering 5-FLUOROURACIL; ABIRATERONE ACETATE; AFATINIB DIMALEATE; ALBUTEROL SULPHATE (SALBUTAMOL); ALCLOMETASONE DIPROPIONATE; ALENDRONATE MONOSODIUM TRIHYDRATE.

API / Drug Master Files

TAPI NL BV holds 330 active (330 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• MAVACAMTENActive2026-03-12
• IXAZOMIB CITRATEActive2026-02-04
• CAPMATINIB DIHYDROCHLORIDE MONOHYDRATEActive2026-01-27
• PALIPERIDONE PALMITATE STERILEActive2025-12-22
• TIRZEPATIDEActive2025-12-15
• SEMAGLUTIDEActive2025-12-10
• TAPINAROFActive2025-11-30
• PACRITINIB CITRATEActive2025-09-07
• SOTORASIBActive2025-07-15
• APIXABAN PActive2025-06-17
• BELUMOSUDIL MESYLATEActive2025-05-25
• OLANZAPINE FORM IIActive2025-04-02
• FINERENONEActive2025-03-13
• SAMIDORPHAN L-MALATEActive2024-12-19
• TRILACICLIBActive2024-09-05

Showing 15 of 330 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to TAPI NL BV in our records. PharmaTek screens the full directory against live FDA enforcement data.